Briefing: Biotech investors’ plea to Trump, and a busy M&A week
Strategic angle: How has the FDA's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep medicine?
Latest North America stories from World.
Strategic angle: How has the FDA's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep medicine?
Strategic angle: Kristin drives a lot for both her work and hobbies. Her 2011 Jeep Grand Cherokee is getting old. With a budget of $25,000, what car should she buy?
Strategic angle: I won't go so far as to say car shows are back, but this one could definitely be a bit of an indication that the tides are turning.
Strategic angle: Scientists at the National Graphene Institute have developed a groundbreaking technique to visualize gold atoms in motion.
Strategic angle: This is the first post in a series on 3D print blocking, for the next entry check out Print Blocking Won't Work - Permission to Print Part 2 When legislators give companies an excuse to write untouchable code, it’s a dis
Strategic angle: Exploring potential refunds for energy projects following recent IEEPA ruling.
Strategic angle: A common antidepressant detected in rivers and streams worldwide is disrupting how fish learn, with significant implications for aquatic ecosystems.
Strategic angle: Memorable moments from auto shows featuring iconic cars.
Strategic angle: A seat supplier changed its manufacturing process without approval, and now 4,476 Gravity owners are paying the price.
Strategic angle: Slow first-quarter demand left carmaker with more than 50,000 unsold units at start of year
Strategic angle: These are a few of the EVs that the audience thinks should be canceled next.
Strategic angle: The Intergovernmental Panel on Climate Change’s (IPCC) latest assessment cycle has been beset by disagreements... The post Q&A: Why the standoff between nations over the next IPCC reports matters appeared first on Carbon
Strategic angle: Potential import tariffs on drugs, Foundayo is here-o, and other biotech news from The Readout
Strategic angle: The FDA approves a new obesity pill from Lilly amidst tariff discussions.
Strategic angle: Ahead of All-Weather Finals Day, experts discuss top fancies for Newcastle's flagship meeting.
Strategic angle: The suspect is in custody but his motive is unknown, the police say in a brief statement.
Strategic angle: A historic day at the Supreme Court as President Trump attends oral arguments.
Strategic angle: Ahead of the 2026 midterm elections, this KFF issue brief examines the role health care has played in previous elections and its potential impact in 2026.
Strategic angle: U.S. exceptionalism is "no longer automatic" among global investors, one market watcher told CNBC.
Strategic angle: Despite the recent EV slowdown, the American-made Ioniq 5 is winning hearts left and right, with double-digit sales increases.